Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
Clinical trial NCT01159912 · COMPLETED
Trial details
- NCT number
- NCT01159912
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-30
- Primary completion
- 2012-01-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.